COVID-19 mRNA Based Vaccine Immune-Response Assessment in Nursing Home Residents for Public Health Decision

Nursing home residents (NHR) have been targeted as a vaccination priority due to their higher risk of worse outcome after COVID-19 infection. The mRNA-based vaccine BTN2b2 was first approved in Europe for NHRs. The assessment of the specific vaccine immune response (both humoral and cellular) at lon...

Descripción completa

Detalles Bibliográficos
Autores principales: San Segundo, David, Comins-Boo, Alejandra, Lamadrid-Perojo, Patricia, Irure-Ventura, Juan, Castillo-Otí, José María, Wallman, Reinhard, Calvo-Montes, Jorge, Méndez-Legaza, José Manuel, Baamonde-Calzada, Carmela, Sánchez-Molina, Isabel, Lecue-Martínez, Marina, Ventisca-Pérez, Silvia, Batlle-López, Ana, Hoyos, Marcos López
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8703754/
https://www.ncbi.nlm.nih.gov/pubmed/34960173
http://dx.doi.org/10.3390/vaccines9121429

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8703754/
https://www.ncbi.nlm.nih.gov/pubmed/34960173
http://dx.doi.org/10.3390/vaccines9121429

Ejemplares similares